CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis
β Scribed by Wutte, N.; Kovacs, G.; Berghold, A.; Reiter, H.; Aberer, W.; Aberer, E.
- Book ID
- 125466516
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 140 KB
- Volume
- 169
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To determine phenotypic and functional abnormalities of blood B cell subsets in patients with systemic sclerosis (SSc). ## Methods Cell surface marker expression was determined by flow cytometry. Spontaneous apoptosis was evaluated by annexin V expression with flow cytom
## Abstract It has recently been found that excessive serum Bβcell activating factor (BAFF) production triggers severe autoimmune disorders in mice resembling systemic lupus erythematosus (SLE). Whether such dysregulation in circulating levels of BAFF results from overexpression of BAFF gene in cli